Eupatilin inhibits the proliferation of human esophageal cancer TE1 cells by targeting the Akt ‑GSK3β and MAPK/ERK signaling cascades.

In conclusion, the present results indicate that the antiproliferative effect of eupatilin on esophageal cancer TE1 cells is associated with inhibition of the Akt and ERK pathways. PMID: 29693162 [PubMed - as supplied by publisher]
Source: Oncology Reports - Category: Cancer & Oncology Tags: Oncol Rep Source Type: research